Update: The FDA reversed its decision on Feb. 18 and agreed to consider Moderna's application. Read the latest here. Our earlier story is below. The Food and Drug Administration is refusing to ...
The Food and Drug Administration has refused to start a review of Moderna's application for its experimental flu shot, the company said. It's another sign of the Trump administration's influence on ...
The FDA is changing how food manufacturers can make “no artificial colors” claims, allowing greater flexibility for products containing naturally derived color additives. But some industry and ...
OpenAI is releasing a new app called Prism today, and it hopes it does for science what coding agents like Claude Code and its own Codex platform have done for programming. Prism builds on Crixet, a ...
The new Prescription Drug User Fee Act target date is now April 13, 2026. The Food and Drug Administration (FDA) has extended the review period for sparsentan in focal segmental glomerulosclerosis ...
The U.S. Agency for International Development has been a major supporter of global agriculture research. Now many studies are being scuttled or scaled back. By Ted Alcorn Crops and livestock that are ...
The FDA is expected to decide on whether to approve the first gene therapy for mucopolysaccharidosis II (MPS II), also known as Hunter syndrome. MPS II is a rare, X-linked recessive disorder caused by ...
Rusfertide is a first-in-class hepcidin mimetic peptide for polycythemia vera, aiming to regulate iron homeostasis and red blood cell production. Phase 3 VERIFY and phase 2 REVIVE studies demonstrated ...
W.L. Gore & Associates has received FDA approval for the Gore Viabahn Fortegra Venous Stent — the first device indicated to treat deep venous disease in the inferior vena cava, as well as the iliac ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Following the recent approval of nerandomilast tablets for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, the FDA has approved the medication for progressive pulmonary fibrosis as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results